Bridgebio Oncology Therapeutics, Inc. (BBOT)
7.47
+0.35
(+4.92%)
USD |
NASDAQ |
Jun 11, 16:00
7.47
0.00 (0.00%)
After-Hours: 18:27
Bridgebio Oncology Therapeutics Accounts Payable (Quarterly) : 12.09M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 12.09M |
| December 31, 2025 | 1.374M |
| September 30, 2025 | 3.65M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 3.074M |
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Erasca, Inc. | 2.163M |
| Bicara Therapeutics, Inc. | 7.44M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | 19.31M |